UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule (13d-101) INFORMATION TO BE INCLUDED IN...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 3...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of...
Interpharm Holdings, Inc. (Amex: IPA) (?Interpharm?), a manufacturer and distributor of generic pharmaceutical products...
Interpharm Holdings, Inc. (Amex: IPA)(?Holdings?), a manufacturer and distributor of generic pharmaceutical products, announced...
FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________ FORM 10-Q _____________ x QUARTERLY REPORT UNDE...
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING |_| Form 10-K and Form 10-KSB |_| Form...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.